PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.
Jeremy Grantham's Strategic Moves: A Closer Look at Thermo Fisher Scientific Inc.
The most notable increase was Thermo Fisher Scientific Inc (NYSE:TMO), with an additional 639,467 shares, bringing the total to 1,093,866 shares. This adjustment represents a significant 140.73% ...
Thermo Fisher Scientific is recognized as a star player in Lab Informatics space by MarketsandMarkets' 360Quadrants
Thermo Fisher Scientific has been recognized as a star player in the laboratory informatics market on the 360Quadrants ...
Is Thermo Fisher Scientific Inc. (TMO) the Best Medical Device Stock to Buy?
We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...
Mass Spectrometry Market worth $9.62 billion by 2030
Browse 400 market data Tables and 50 Figures spread through 250 Pages and in-depth TOC on "Mass Spectrometry Market by ...
10x Genomics price target lowered to $18 from $19 at Barclays
Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
Bruker price target lowered to $65 from $69 at Barclays
Barclays analyst Luke Sergott lowered the firm’s price target on Bruker to $65 from $69 and keeps an Overweight rating on the shares. The firm ...